Identification of a possible role for atrial natriuretic peptide in MDMA-induced hyperthermia

Sandra L Hrometz1, Karen E Thatcher, Jeremy A Ebert

  • 1Department of Pharmaceutical and Biomedical Sciences, The Raabe College of Pharmacy, Ohio Northern University, 525 S. Main Street, Ada, OH 45810, USA.

Toxicology Letters
|August 11, 2011
PubMed

Insights

MDMA increases body temperature through a process involving atrial natriuretic peptide (ANP). Blocking ANP signaling with Anantin reduced this MDMA-induced hyperthermia in rats.

Area of Science:

  • Pharmacology
  • Physiology
  • Biochemistry

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA) induces thermogenesis, partly via lipolytic release of free fatty acids activating uncoupling protein 3.
  • Atrial natriuretic peptide (ANP) is a potent lipolytic mediator, suggesting a potential role in MDMA-induced thermogenesis.

Purpose of the Study:

  • To investigate if ANP is released after MDMA administration.
  • To determine the role of ANP in MDMA-induced hyperthermia using an ANP receptor antagonist.

Main Methods:

  • Male Sprague-Dawley rats (n=16) received MDMA (40 mg/kg, sc).
  • Plasma ANP levels were measured at baseline and at 10, 20, 30, and 60 minutes post-administration.
  • The ANP receptor antagonist, Anantin (40 mg, ip), was administered before and after MDMA.

Main Results:

  • MDMA administration caused a rapid increase in plasma ANP levels within 10 minutes.
  • ANP levels initially returned to baseline before rising again over 60 minutes.
  • Anantin treatment significantly attenuated the hyperthermia induced by MDMA.

Conclusions:

  • ANP signaling plays a significant role in the hyperthermia induced by MDMA.
  • These findings suggest ANP as a key mediator in MDMA's thermogenic effects.

Related Concept Videos